Follow-up after surgical treatment of bladder cancer: A critical analysis of the literature

European Urology

Volumn 62, Issue 2, 2012, Pages 290-302

  Soukup, Viktor ^a   Babjuk, Marko ^b   Bellmunt, Joaquim ^c   Dalbagni, Guido ^d   Giannarini, Gianluca ^e   Hakenberg, Oliver W ^f   Herr, Harry ^d   Lechevallier, Eric ^g   Ribal, Maria J ^h  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^c HOSPITAL DEL MAR   (Spain)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e UNIVERSITY OF BERN   (Switzerland)

^f UNIVERSITY OF ROSTOCK   (Germany)

^g HÔPITAL DE LA CONCEPTION   (France)

^h UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Cystoscopy; Follow up; Muscle invasive bladder cancer; Non muscle invasive bladder cancer; Progression; Radical cystectomy; Recurrence

Indexed keywords

NUCLEAR MATRIX PROTEIN 22;

BLADDER BIOPSY; BLADDER CANCER; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER GROWTH; CANCER PATIENT; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; COCHRANE LIBRARY; CYANOCOBALAMIN DEFICIENCY; CYSTECTOMY; CYSTOSCOPY; DIAGNOSTIC TEST ACCURACY STUDY; DISTANT METASTASIS; EARLY DIAGNOSIS; EMBASE; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HUMAN; LYMPH NODE METASTASIS; MEDLINE; MEGALOBLASTIC ANEMIA; METABOLIC ACIDOSIS; MICROSATELLITE MARKER; NON MUSCLE INVASIVE BLADDER CANCER; PRIORITY JOURNAL; RECURRENCE RISK; REVIEW; SENSITIVITY AND SPECIFICITY; SYSTEMATIC REVIEW; TRANSURETHRAL RESECTION; URETER OBSTRUCTION; URINARY DIVERSION; URINARY TRACT INFECTION; URINE CYTOLOGY; URINE INCONTINENCE; URINE RETENTION; UROLITHIASIS;

BIOLOGICAL MARKERS; BIOPSY; CARCINOMA; CYSTECTOMY; CYSTOSCOPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 84862848719     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2012.05.008     Document Type: Review

References (92)

1. M. Babjuk, W. Oosterlinck, and R. Sylvester EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update Eur Urol 59 2011 997 1008
2. R.J. Sylvester, A.P.M. van der Meijden, and W. Oosterlinck Predicting recurrence and progression in individual patients with stage TaT1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials Eur Urol 49 2006 466 477
3. J. Fernandez-Gomez, R. Madero, and E. Solsona Predicting nonmuscle invasive bladder cancer recurrence and progression in patients treated with bacillus Calmette-Guerin: the CUETO scoring model J Urol 182 2009 2195 2203
4. M.C. Hall, S.S. Chang, and G. Dalbagni Guideline for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 Update J Urol 178 2007 2314 2330 (Pubitemid 350080987)
5. A. Stenzl, N.C. Cowan, and M. De Santis Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines Eur Urol 59 2011 1009 1018
6. Philips B, Ball C, Sackett D, et al. Oxford Centre for Evidence-Based Medicine: levels of evidence. Centre for Evidence-Based Medicine Web site. http://www.cebm.net/index.aspx?o=1025. Updated September 2011. Accessed August 5, 2009.
7. J. Fernandez-Gomez, R. Madero, and E. Solsona The EORTC tables overestimate the risk of recurrence and progression in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: external validation of the EORTC risk tables Eur Urol 60 2011 423 430
8. S. Holmang, and S.L. Johansson Stage Ta-T1 bladder cancer: the relationship between findings at first followup cystoscopy and subsequent recurrence and progression J Urol 167 2002 1634 1637 (Pubitemid 34240688)
9. M.P.J. Wright, and D.J. Jones Surveillance for bladder cancer: the management of 4.8 million people BJU Int 85 2000 431 433 (Pubitemid 30142617)
10. M. Brausi, L. Collette, and K. Kurth Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: a combined analysis of seven EORTC studies Eur Urol 41 2002 523 531
11. J. Fernandez-Gomez, E. Solsona, and M. Unda Prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: multivariate analysis of data from four randomized CUETO trials Eur Urol 53 2008 992 1002 (Pubitemid 351434495)
12. K.H. Kurth, L. Denis, and C. Bouffioux Factors affecting recurrence and progression in superficial bladder tumours Eur J Cancer 31A 1995 1840 1846
13. M.K. Parmar, L.S. Freedman, T.B. Hargreave, and D.A. Tolley Prognostic factors for recurrence and followup policies in the treatment of superficial bladder cancer: report from the British Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party) J Urol 142 1989 284 288 (Pubitemid 19197097)
14. H.W. Herr Progression of stage T1 bladder tumors after intravesical bacillus Calmette-Guerin J Urol 145 1991 40 43 discussion 43-4
15. O. Öge, E. Erdem, N. Atsü, A. Ahin, and H. Özen Proposal for changes in cystoscopic follow-up of patients with low-grade pTa bladder tumor Eur Urol 37 2000 271 274 (Pubitemid 30122259)
16. E. Solsona, I. Iborra, R. Dumont, J. Rubio-Briones, J. Casanova, and S. Almenar The 3-month clinical response to intravesical therapy as a predictive factor for progression in patients with high risk superficial bladder cancer J Urol 164 2000 685 689 (Pubitemid 30637602)
17. J. Palou, F. Rodríguez-Rubio, and F. Millán Recurrence at three months and high-grade recurrence as prognostic factor of progression in multivariate analysis of T1G2 bladder tumors Urology 73 2009 1313 1317
18. J.A. Witjes, D.O.T.M. Melissen, and L.A.L.M. Kiemeney Current practice in the management of superficial bladder cancer in the Netherlands and Belgian Flanders: a survey Eur Urol 49 2006 478 484 (Pubitemid 43259556)
19. K. Chamie, C.S. Saigal, and J. Lai Compliance with guidelines for patients with bladder cancer: variation in the delivery of care: The Urologic Diseases in America Project Cancer 11 2011 1 10
20. L.H. Olsen, and H.G. Genster Prolonging follow-up intervals for non-invasive bladder tumors: a randomized controlled trial Scand J Urol Nephrol Suppl 172 1995 33 36
21. R.R. Hall, M.K.B. Parmar, A.B. Richards, and P.H. Smith Proposal for changes in cystoscopic follow-up of patients with bladder cancer and adjuvant intravesical chemotherapy BMJ 308 2004 257 260
22. S. Holmäng, and V. Ströck Should follow-up cystoscopy in bacillus Calmette-Guérin-treated patients continue after five tumour-free years? Eur Urol 61 2012 503 507
23. P. Mariappan, and G. Smith A surveillance schedule for G1Ta bladder cancer allowing efficient use of check cystoscopy and safe discharge at 5 years based on a 25-year prospective database J Urol 173 2005 1108 1111 (Pubitemid 40380512)
24. J.M. Fitzpatrick, A.B. West, M.R. Butler, V. Lane, and J.D. O'Flynn Superficial bladder tumors (stage pTa, grades 1 and 2): the importance of recurrence pattern following initial resection J Urol 135 1986 920 922 (Pubitemid 16077209)
25. S. Holmäng, H. Hedelin, C. Anderström, and S.L. Johansson The relationship among multiple recurrences, progression and prognosis of patients with stages Ta and T1 transitional cell cancer of the bladder followed for at least 20 years J Urol 153 1995 1823 1826 discussion 1826-7
26. S.B. Morris, E.M. Gordon, R.J. Shearer, and C.R. Woodhouse Superficial bladder cancer: for how long should a tumour-free patient have check cystoscopies? Br J Urol 75 1995 193 196
27. B. Leblanc, A.J. Duclos, and F. Bénard Long-term followup of initial Ta grade 1 transitional cell carcinoma of the bladder J Urol 162 1999 1946 1950
28. Y. Fujii, S. Kawakami, F. Koga, T. Nemoto, and K. Kihara Long-term outcome of bladder papillary urothelial neoplasms of low malignant potential BJU Int 92 2003 559 562 (Pubitemid 37271729)
29. W. Oosterlinck, E. Solsona, and H. Akaza Low-grade Ta (noninvasive) urothelial carcinoma of the bladder Urology 66 2005 75 89 (Pubitemid 43049610)
30. G. Mowatt, S. Zhu, and M. Kilonzo Systematic review of the clinical effectiveness and cost-effectiveness of photodynamic diagnosis and urine biomarkers (FISH, ImmunoCyt, NMP22) and cytology for the detection and follow-up of bladder cancer Health Technol Assess 14 2010 1 331 iii-iv
31. E.C. Cauberg, S. Kloen, and M. Visser Narrow band imaging cystoscopy improves the detection of non-muscle-invasive bladder cancer Urology 76 2010 658 663
32. W. Loidl, J. Schmidbauer, M. Susani, and M. Marberger Flexible cystoscopy assisted by hexaminolevulinate induced fluorescence: a new approach for bladder cancer detection and surveillance? Eur Urol 47 2005 323 326 (Pubitemid 40248853)
33. H.W. Herr, and S.M. Donat Reduced bladder tumour recurrence rate associated with narrow-band imaging surveillance cystoscopy BJU Int 107 2011 396 398
34. E.C.C. Cauberg, D.M. de Bruin, D.J. Faber, T.G. van Leeuwen, J.J.M.C.H. de la Rosette, and T.M. de Reijke A new generation of optical diagnostics for bladder cancer: technology, diagnostic accuracy, and future applications Eur Urol 56 2009 287 297
35. M.N. van der Aa, E.W. Steyerberg, C. Bangma, B.W. van Rhijn, E.C. Zwarthoff, and T.H. van der Kwast Cystoscopy revisited as the gold standard for detecting bladder cancer recurrence: diagnostic review bias in the randomized, prospective CEFUB trial J Urol 183 2010 76 80
36. H.W. Herr, R.A. Badalament, D.A. Amato, V.P. Laudone, W.R. Fair, and W.F. Whitmore Jr. Superficial bladder cancer treated with bacillus Calmette-Guerin: a multivariate analysis of factors affecting tumor progression J Urol 141 1989 22 29 (Pubitemid 19028816)
37. G. Dalbagni, T. Rechtschaffen, and H.W. Herr Is transurethral biopsy of the bladder necessary after 3 months to evaluate response to bacillus Calmette-Guerin therapy? J Urol 162 1999 708 709 (Pubitemid 29436855)
38. O. Yossepowitch, H.W. Herr, and S.M. Donat Use of urinary biomarkers for bladder cancer surveillance: patient perspectives J Urol 177 2007 1277 1282 (Pubitemid 46436000)
39. O.P. Vrooman, and J.A. Witjes Molecular markers for detection, surveillance and prognostication of bladder cancer Int J Urol 16 2009 234 243
40. L. Mengual, M. Marín-Aguilera, and M.J. Ribal Clinical utility of fluorescent in situ hybridization for the surveillance of bladder cancer patients treated with bacillus Calmette- Guérin therapy Eur Urol 52 2007 752 759 (Pubitemid 47126159)
41. A.P. Mitra, and R.J. Cote Molecular screening for bladder cancer: progress and potential Nat Rev Urol 7 2010 11 20
42. D. Tilki, M. Burger, and G. Dalbagni Urine markers for detection and surveillance of non-muscle-invasive bladder cancer Eur Urol 60 2011 484 492
43. B.W.G. van Rhijn, H.G. van der Poel, and T.H. van der Kwast Urine markers for bladder cancer surveillance: a systematic review Eur Urol 47 2005 736 748 (Pubitemid 40745338)
44. L. Mengual, M. Burset, and M.J. Ribal Gene expression signature in urine for diagnosing and assessing aggressiveness of bladder urothelial carcinoma Clin Cancer Res 16 2010 2624 2633
45. T.F. Wu, W.L. Ku, and Y.G. Tsay Proteome-based diagnostics and prognosis of bladder transitional cell carcinoma Expert Rev Proteomics 4 2007 639 647
46. R.H. Cohan, E.M. Caoili, N.C. Cowan, A.Z. Weizer, and J.H. Ellis MDCT urography: exploring a new paradigm for imaging of bladder cancer AJR Am J Roentgenol 192 2009 1501 1508
47. K. Stamatiou, H. Moschouris, M. Papadaki, G. Perlepes, and A. Skolarikos Accuracy of modern ultrasonographic techniques in the follow up of patients with superficial bladder carcinoma Med Ultrason 13 2011 114 119
48. X. Qu, X. Huang, L. Wu, G. Huang, X. Ping, and W. Yan Comparison of virtual cystoscopy and ultrasonography for bladder cancer detection: a meta-analysis Eur J Radiol 80 2010 188 197
49. F. Millán-Rodríguez, G. Chéchile-Toniolo, J. Salvador-Bayarri, J. Huguet-Pérez, and J. Vicente-Rodríguez Upper urinary tract tumors after primary superficial bladder tumors: prognostic factors and risk groups J Urol 164 2000 1183 1187
50. J.L. Wright, J. Hotaling, and M.P. Porter Predictors of upper tract urothelial cell carcinoma after primary bladder cancer: a population based analysis AS J Urol 181 2009 1035 1039
51. R. Hurle, A. Losa, A. Manzetti, and A. Lembo Upper urinary tract tumors developing after treatment of superficial bladder cancer: 7-year follow-up of 591 consecutive patients Urology 53 1999 1144 1148 (Pubitemid 29264744)
52. E. Solsona, I. Iborra, J.V. Ricós, R. Dumont, J.L. Casanova, and C. Calabuig Upper urinary tract involvement in patients with bladder carcinoma in situ (Tis): its impact on management Urology 49 1997 347 352 (Pubitemid 27138674)
53. D.M. Yousem, O.M. Gatewood, S.M. Goldman, and F.F. Marshall Synchronous and metachronous transitional cell carcinoma of the urinary tract: prevalence, incidence, and radiographic detection Radiology 167 1988 613 618
54. J. Palou, L.A. Farina, H. Villavicencio, and J. Vicente Upper tract urothelial tumor after transurethral resection for bladder tumor Eur Urol 21 1992 110 114
55. J. Palou, F. Rodríguez-Rubio, and J. Huguet Multivariate analysis of clinical parameters of synchronous primary superficial bladder cancer and upper urinary tract tumor J Urol 174 2005 859 861 (Pubitemid 41140611)
56. H.W. Herr, M.S. Cookson, and S.M. Soloway Upper tract tumors in patients with primary bladder cancer followed for 15 years J Urol 156 1996 1286 1287 (Pubitemid 26307595)
57. M. Rouprêt, R. Zigeuner, and J. Palou European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update Eur Urol 59 2011 584 594
58. R.E. Hautmann, J.E. Gschwend, R.C. de Petriconi, M. Kron, and B.G. Volkmer Cystectomy for transitional cell carcinoma of the bladder: results of a surgery only series in the neobladder era J Urol 176 2006 486 492 (Pubitemid 43927871)
59. P.I. Karakiewicz, S.F. Shariat, and G.S. Palapattu Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder J Urol 176 2006 1354 1361
60. International Bladder Cancer Nomogram Consortium B.H. Bochner, M.W. Kattan, and K.C. Vora Postoperative nomogram predicting risk of recurrence after radical cystectomy for bladder cancer J Clin Oncol 24 2006 3967 3972 (Pubitemid 46630745)
61. O.P. Vrooman, and J.A. Witjes Follow-up of patients after curative bladder cancer treatment: guidelines vs. practice Curr Opin Urol 20 2010 437 442
62. E.C. Umbreit, P.L. Crispen, M.S. Shimko, S.A. Farmer, M.L. Blute, and I. Frank Multifactorial, site-specific recurrence model after radical cystectomy for urothelial carcinoma Cancer 116 2010 3399 3407
63. B.G. Volkmer, R. Kuefer, G.C. Bartsch Jr., K. Gust, and R.E. Hautmann Oncological followup after radical cystectomy for bladder cancer: is there any benefit? J Urol 181 2009 1587 1593
64. N.B. Dhar, J.S. Jones, and A.M. Reuther Presentation, location and overall survival of pelvic recurrence after radical cystectomy for transitional cell carcinoma of the bladder BJU Int 101 2008 969 972 (Pubitemid 351422548)
65. G. Giannarini, T.M. Kessler, H.C. Thoeny, D.P. Nguyen, C. Meissner, and U.E. Studer Do patients benefit from routine follow-up to detect recurrences after radical cystectomy and ileal orthotopic bladder substitution? Eur Urol 58 2010 486 494
66. I. Cagiannos, and C. Morash Surveillance strategies after definitive therapy of invasive bladder cancer Can Urol Assoc J 3 2009 S237 S242
67. S.M. Donat Staged based directed surveillance of invasive bladder cancer following radical cystectomy: valuable and effective? World J Urol 24 2006 557 564 (Pubitemid 44782309)
68. T. Okegawa, K. Hayashi, H. Hara, K. Nutahara, and E. Higashihara Immunomagnetic quantification of circulating tumor cells in patients with urothelial cancer Int J Urol 17 2010 254 258
69. A. Nezos, N. Pissimisis, and P. Lembessis Detection of circulating tumor cells in bladder cancer patients Cancer Treat Rev 35 2009 272 279
70. I. Osman, D.F. Bajorin, and T.T. Sun Novel blood biomarkers of human urinary bladder cancer Clin Cancer Res 12 2006 3374 3380
71. K. Schwamborn, R.C. Krieg, and J. Grosse Serum proteomic profiling in patients with bladder cancer Eur Urol 56 2009 989 997
72. A.K. Levinson, D.E. Johnson, and K.I. Wishnow Indications for urethrectomy in an era of continent urinary diversion J Urol 144 1990 73 75 (Pubitemid 20221273)
73. H.B. Tongaonkar, A.V. Dalal, J.N. Kulkarni, and M.R. Kamat Urethral recurrences following radical cystectomy for invasive transitional cell carcinoma of the bladder Br J Urol 72 1993 910 914 (Pubitemid 24053511)
74. P.E. Clark, J.P. Stein, and S.G. Groshen The management of urethral transitional cell carcinoma after radical cystectomy for invasive bladder cancer J Urol 172 2004 1342 1347 (Pubitemid 39249711)
75. J.P. Stein, P. Clark, G. Miranda, J. Cai, S. Groshen, and D.G. Skinner Urethral tumor recurrence following cystectomy and urinary diversion: clinical and pathological characteristics in 768 male patients J Urol 173 2005 1163 1168 (Pubitemid 40380525)
76. R.E. Hautmann, B.G. Volkmer, M.C. Schumacher, J.E. Gschwend, and U.E. Studer Long-term results of standard procedures in urology: the ileal neobladder World J Urol 24 2006 305 314 (Pubitemid 44138185)
77. U.E. Studer, F.C. Burkhard, and M. Schumacher Twenty years experience with an ileal orthotopic low pressure bladder substitute - lessons to be learned J Urol 176 2006 161 166 (Pubitemid 43815402)
78. J.B. Sherwood, and A.I. Sagalowsky The diagnosis and treatment of urethral recurrence after radical cystectomy Urol Oncol 24 2006 356 361 (Pubitemid 43963412)
79. J. Huguet, V. Monllau, and S. Sabaté Diagnosis, risk factors, and outcome of urethral recurrences following radical cystectomy for bladder cancer in 729 male patients Eur Urol 53 2008 785 793
80. B. Ali-el-Dein, M. Abdel-Latif, A. Ashamallah, M. Abdel-Rahim, and M. Ghoneim Local urethral recurrence after radical cystectomy and orthotopic bladder substitution in women: a prospective study J Urol 171 2004 275 278 (Pubitemid 37549142)
81. T. Akkad, C. Gozzi, and M. Deibl Tumor recurrence in the remnant urothelium of females undergoing radical cystectomy for transitional cell carcinoma of the bladder: long-term results from a single center J Urol 175 2006 1268 1271
82. J.P. Stein, D.F. Penson, C. Lee, J. Cai, G. Miranda, and D.G. Skinner Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer J Urol 181 2009 2052 2058
83. S.A. Boorjian, S.P. Kim, C.J. Weight, J.C. Cheville, P. Thapa, and I. Frank Risk factors and outcomes of urethral recurrence following radical cystectomy Eur Urol 60 2011 1266 1272
84. J. Huguet-Pérez, J. Palou, F. Millán-Rodríguez, J. Salvador-Bayarri, H. Villavicencio-Mavrich, and J. Vicente-Rodríguez Upper tract transitional cell carcinoma following cystectomy for bladder cancer Eur Urol 40 2001 318 323 (Pubitemid 34701903)
85. K.M. Sanderson, J. Cai, G. Miranda, D.G. Skinner, and J.P. Stein Upper tract urothelial recurrence following radical cystectomy for transitional cell carcinoma of the bladder: an analysis of 1,069 patients with 10-year followup J Urol 177 2007 2088 2094 (Pubitemid 46726402)
86. C. Meissner, G. Giannarini, M.C. Schumacher, H. Thoeny, U.E. Studer, and F.C. Burkhard The efficiency of excretory urography to detect upper urinary tract tumors after cystectomy for urothelial cancer J Urol 178 2007 2287 2290 (Pubitemid 350052185)
87. B.G. Volkmer, T. Schnoeller, R. Kuefer, K. Gust, F. Finter, and R.E. Hautmann Upper urinary tract recurrence after radical cystectomy for bladder cancer - who is at risk? J Urol 182 2009 2632 2637
88. W. Tran, A.M. Serio, and G.V. Raj Longitudinal risk of upper tract recurrence following radical cystectomy for urothelial cancer and the potential implications for long-term surveillance J Urol 179 2008 96 100 (Pubitemid 350216731)
89. G.V. Raj, B.H. Bochner, and A.M. Serio Natural history of positive urinary cytology after radical cystectomy J Urol 176 2006 2000 2005 (Pubitemid 44633137)
90. D.R. Duerksen, G. Fallows, and C.N. Bernstein Vitamin B12 malabsorption in patients with limited ileal resection Nutrition 22 2006 1210 1213 (Pubitemid 44692455)
91. R.D. Mills, and U.E. Studer Metabolic consequences of continent urinary diversion J Urol 161 1999 1057 1066 (Pubitemid 29426087)
92. S. Madersbacher, J. Schmidt, and J.M. Eberle Long-term outcome of ileal conduit diversion J Urol 169 2003 985 990 (Pubitemid 36188140)